Live Breaking News & Updates on Zoommed Inc

BROSSARD, Quebec, May 11, 2021 (GLOBE NEWSWIRE)
ZoomMed Inc. (the “Corporation” or “ZoomMed”) (TSX Venture Exchange:ZMD) is proud to announce that the transaction to acquire the intellectual property rights of the ZRx Prescriber to develop, market and operate the ZRx Prescriber in the United States, Europe and the United Kingdom has been completed with the wholly owned subsidiary KDA Technological Group inc. (“KDA Techno”) of the KDA Group inc. (“KDA”).
Group KDA will issue ZoomMed 10,000,000 common class A shares of its share capital (the “Common Shares”) at a deemed value of $3,140,000 CND, based on the average closing price of the Common Shares for the last 52 weeks. The Transaction is effective as of May 10, 2021. Pursuant to the Asset Purchase Agreement, 10,000,000 of the 20,000,000 KDA Shares will be held in escrow and released as follows: 5,000,000 of KDA Shares will be released on the first anniversary date (12 months) of the closing, being M ....

United States , United Kingdom , Yves Marmet , Zoommed Communication Network , Regulation Services Provider , Venture Exchange , Zoommed Inc , Corporation Or Zoommed , Technological Group , Common Shares , Asset Purchase Agreement , Communication Network , Electronic Medical Record , Chief Executive Officer , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் , ஒழுங்குமுறை சேவைகள் வழங்குநர் , துணிகர பரிமாற்றம் , தொழில்நுட்ப குழு , பொதுவானது பங்குகள் , தொடர்பு வலைப்பின்னல் , மின்னணு மருத்துவ பதிவு , தலைமை நிர்வாகி அதிகாரி ,